Ira Krefting, MD brings to clients 17 years of FDA experience and over 25 years of medical practice while performing clinical trials. Having served as the Deputy Director for Safety in the Office of New Drugs, Division of Imaging and Radiation Medicine, I can provide clients with expert advice on the development of novel imaging agents and potentially related safety concerns. I am the recipient of FDA group awards for the management of safety issues and have managed clinical and pre-clinical research projects. As the supervisory medical officer for the Radioactive Drug Research Committee, I have extensive knowledge of the early development of novel Positron Emission Tomography (PET) agents Dr. Krefting works with the client to formulate detailed solutions that satisfy regulatory requirements and provide the public with products that are safe and efficacious.